Back to the future: Multiagent chemotherapy in ovarian cancer revisited

被引:8
作者
Cannistra, SA [1 ]
机构
[1] Beth Israel Deaconess Med Ctr, Boston, MA USA
关键词
D O I
10.1200/JCO.1999.17.3.741
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:741 / 743
页数:3
相关论文
共 13 条
[11]   Prolonged oral etoposide as second-line therapy for platinum-resistant and platinum-sensitive ovarian carcinoma: A gynecologic oncology group study [J].
Rose, PG ;
Blessing, JA ;
Mayer, AR ;
Homesley, HD .
JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (02) :405-410
[12]   THE CURRENT STATUS OF CAMPTOTHECIN ANALOGS AS ANTITUMOR AGENTS [J].
SLICHENMYER, WJ ;
ROWINSKY, EK ;
DONEHOWER, RC ;
KAUFMANN, SH .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1993, 85 (04) :271-291
[13]  
vanMoorsel CJA, 1997, SEMIN ONCOL, V24, pS17